X

Trial Profile

An Open Label Study of Adefovir Dipivoxil for the Treatment of Patients With Chronic Hepatitis B Related Advanced Fibrosis or Cirrhosis.

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 02 Jul 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Adefovir dipivoxil (Primary)
Indications Hepatitis B
Focus Therapeutic Use
Sponsors GlaxoSmithKline; GSK

Most Recent Events

16 May 2010 Actual patient number added as 155 as reported by ClinicalTrials.gov.
16 May 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
16 May 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com